Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: Comparison with injected Zn-DTPA in the rat

Radiation Protection Dosimetry

Volumn 118, Issue 4, 2006, Pages 412-420

  Miller, Scott C ^a   Liu, Gang ^a   Bruenger, Fred W ^a   Lloyd, Ray D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 N DOCOSYLTRIETHYLENETETRAMINEPENTAACETIC ACID; 1 N DODECYLTRIETHYLENETETRAMINEPENTAACETIC ACID; 1 N HEXADECYLTRIETHYLENETETRAMINEPENTAACETIC ACID; 1 N OCTYLTRIETHYLENETETRAMINEPENTAACETIC ACID; ACTINIDE; AMERICIUM 241; CARBOXYLIC ACID DERIVATIVE; CHELATING AGENT; PENTETATE ZINC; PLUTONIUM 239; TRIETHYLENETETRAMINEPENTAACETIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BONE; CHELATION THERAPY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; LIPOPHILICITY; LIVER; MALE; NONHUMAN; RADIATION INJURY; RAT; TISSUE DISTRIBUTION; TOXICOKINETICS;

ACETIC ACIDS; ADMINISTRATION, ORAL; AMERICIUM; ANIMALS; BONE MARROW; CARBOXYLIC ACIDS; CHELATING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; MALE; PENTETIC ACID; PLUTONIUM; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE DISTRIBUTION; TRIETHYLENETETRAMINE;

EID: 33748206290     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/nci367     Document Type: Article

References (41)

1. World Health Organization. IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation, part 2: Some internally deposited radionuclides. IARC Monographs Vol. 78 (Lyon: IARC) (2001).
2. Dietrich, K. N. et al. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics 114, 19-26 (2004).
3. Mycyk, M. B. and Leikin, J. B. Combined exchange transfusion and chelation therapy for neonatal lead poisoning. Ann. Pharmacother. 38, 821-824 (2004).
4. Breitenstein, B. D. 1976 Hanford americium exposure incident: Medical management and chelation therapy. Health Phys. 45, 855-866 (1983).
5. Bailey, B. R., Eckerman, K. F. and Townsend, L. W. An analysis of a puncture wound case with medical intervention. Radiat. Prot. Dosim. 105, 509-512 (2003).
6. Xu, J., Durbin, P. W., Kullgren, B., Ebbe, S. N., Uhlir, L. C. and Raymond, K. N. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4- carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone. J. Med. Chem. 45, 3963-3971 (2002).
7. Durbin, P. W., Kullgren, B., Xu, J., Raymond, K. N., Henge-Napoli, M. H., Bailly, T. and Burgada, R. Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): Pharmacokinetics and oral efficacy. Radiat. Prot. Dosim. 105, 503-508 (2003).
8. 233U. Radiat. Prot. Dosim. 105, 535-538 (2003).
9. Gorden, A. E., Shuh, D. K., Tiedemann, B. E., Wilson, R. E., Xu, J. and Raymond, K. N. Sequestered plutonium: [Pu(IV){5LIO(me-3,2-HOPO)}(2)] - the first structurally characterized plutonium hydroxypyridonate complex. Chemistry 11, 2842-2848 (2005).
10. Gorden, A. E., Xu, J., Raymond, K. N. and Durbin, P. Rational design of sequestering agents for plutonium and other actinides. Chem. Rev. 103, 4207-4282 (2003).
11. US Food and Drug Administration. FDA approved drugs to treat internal contamination from radioactive elements. FDA Press Release P04-78 (2004).
12. 241Am in rat bones. Radiat. Environ. Biophys. 23, 141-143 (1984).
13. Lloyd, R. D., Taylor, G. N., Mays, C. W., Jones, C. W., Bruenger, F. W. and Atherton, D. R. Dependency of chelation efficiency upon time of first DTPA injection. Radiat. Res. 78, 448-454 (1979).
14. 239Pu Med. Radiol. 13, 10-15 (1968).
15. Stradling, G. N., Gray, S. A., Ellender, M., Pearce, M., Wilson, I., Moody, J. C. and Hodgson, A. Removal of inhaled plutonium and americium from the rat by administration of ZnDTPA in drinking water. Hum. Exp. Toxicol. 12, 233-239 (1993).
16. Bruenger, F. W., Kuswik-Rabiega, G. and Miller, S. C. Decorporation of aged americium deposits by oral administration of lipophilic polyamino carboxylic acids. J. Med. Chem. 35, 112-118, (1992).
17. Miller, S. C., Bruenger, F. W., Kuswik-Rabiega, G., Liu, G. and Lloyd, R. D. Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium. J. Pharmacol. Exp. Ther. 267, 548-554 (1993).
18. Miller, S. C., Bruenger, F. W., Kuswik-Rabiega, G. and Lloyd, R. D. Decorporation of plutonium by oral administration of a partially lipophilic polyamino-carboxylic acid. Health Phys. 63, 195-197 (1992).
19. Sonoda, M., Yoshida, I. and Murase, I. Synthesis and determination of metal chelate stabilities of n-alkyltriethylenetetraaminepentaacetic acid. J. Coord. Chem. 54, 153-165 (2001).
20. 241Am(III) in blood, liver and thyroid. In: Radiobiology of Plutonium. Stover, B. J. and Jee, W. S. S., Eds. (Salt Lake City: J. W. Press) pp. 129-140 (1972).
21. 241Am in beagles by DTPA. Radiat. Res. 62, 97-106 (1975).
22. Rosenthal, M. W., Russell, J. J., Moretti, E. S. and Lindenbaum, A. Effective dose of DTPA, spaced at 3 day intervals, in removal of skeletal plutonium. Health Phys. 16, 806-808 (1969).
23. 239Pu. Health Phys. 22, 761-763 (1972).
24. 239Pu using digitized images of neutron induced autoradiographs. Radiat. Prot. Dosim. 35, 149-157 (1991).
25. Toothacker, L. E. Multiple Comparisons Procedures. Quantitative Applications in the Social Sciences Series No. 89. (Thousand Oaks: Sage Publications), (1993).
26. Aungst, B. J. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82, 979-987 (1993).
27. 238Pu(IV) citrate and 14C-CaNa3-DTPA in mice: comparison with rat, dog, and reference man. Health Phys. 72, 222-235 (1997).
28. Schwartz, S. L., Hayes, J. R., Ide, R. S., Johnson, C. B. and Doolan, P. D. Studies of the nephrotoxicity of ethylenediaminetetraacetic acid. Biochem. Pharmacol. 15, 377-389, (1966).
29. Phan, G., Ramounet-Le Gall, B., Manceau, J., Fanet, M., Benech, H., Fritsch, P., Fattal, E. and Deverre, J. R. Targeting of diethylene-triamine pentaacetic acid encapsulated in liposomes to rat liver: An effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats. Int. J. Radiat. Biol. 80, 413-422 (2004).
30. Suslova, K. G., Khokhryakov, V. F., Tokarskaya, Z. B., Nifatov, A. P., Sokolova, A. B., Kudryavtzeva, T. I., Miller, S. C. and Krahenbuhl, M. P. The effect of state of health on organ distribution and excretion of systemic plutonium in the Mayak workers. Radiat. Prot. Dosim. 105, 229-233 (2003).
31. 241Am III in neonatal beagles. Health Phys. 33, 553-559 (1977).
32. Lloyd, R. D., McFarland, S. S., Atherton, D. R. and Mays, C. W. Plutonium retention, excretion, and distribution in juvenile beagles soon after injection. Radiat. Res. 75, 633-641 (1978)
33. Koshurnikova, N. A., Gilbert, E. S., Sokolnikov, M., Khokhryakov, V. F., Miller, S., Preston, D. L., Romanov, S. A., Shilnikova, N. S., Suslova, K. G. and Vostrotin, V. V. Bone cancers in Mayak workers. Radiat. Res. 154, 237-245 (2000).
34. Gilbert, E. S., Koshurnikova, N. A., Sokolnikov, M., Khokhryakov, V. F., Miller, S., Preston, D. L., Romanov, S. A., Shilnikova, N. S., Suslova, K. G. and Vostrotin, V. V. Liver cancers in Mayak workers. Radiat. Res. 154, 246-252 (2000).
35. 239Pu in the beagle skeleton. Health Phys. 75, 251-258 (1998)
36. Guilmette, R. A., Hakimi, R., Durbin, P. W., Xu, J. and Raymond, K. N. Competitive binding of Pu and Am with bone mineral and novel chelating agents. Radiat. Prot. Dosim. 105, 527-534 (2003).
37. 239Pu in rats. Health Phys. 38, 147-158 (1980).
38. Gray, S. A., Pearce, M. J., Stradling, G. N., Wilson, I., Hodgson, A. and Isaacs, K. R. Optimising the removal of inhaled plutonium and americium from the rat by administration of ZnDTPA in drinking water. Hum. Exp. Toxicol. 14, 902-908 (1995).
39. Stradling, G. N., Hodgson, S. A. and Pearce, M. J. Recent developments in the decorporation of plutonium, americium and thorium. Radiat. Prot. Dosim. 79, 445-448 (1998).
40. Xu, J., Kullgren, B., Durbin, P. W. and Raymond, K. N. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium (IV) chelation. J. Med. Chem. 38, 2606-2614 (1995).
41. Paquet, F., Chazel, V., Houpert, P., Guilmette, R. and Muggenburg, B. Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOX. Radiat. Prot. Dosim. 105, 521-525 (2003).